Hospital General Universitario De Ciudad Real — Clinical Trial Site

16 Registered trials

5 Currently recruiting

Organisation

Hospital General Universitario De Ciudad Real

Location

Ciudad Real, Spain

Identifier

ORG-100049019

Address

Calle Del Obispo Rafael Torija S/n, 13005, Spain

Departments

2140:Nefrología
Allergy
Anestesia
Cardiología
CARDIOLOGY
Cirugía
Department of Anesthesiology, Intensive Care and Pain
Dermatology
ervicio de Anestiología y Reanimación
Flores
Medical Oncology
Oncology
reumatologia
Rheumatology
Servicio de Nefrologia

Clinical trials at this site (16)

Search interface

Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation

2024-514991-41-01 Upper Tract Urothelial Carcinoma. Upper urinary tract t 4
Randomised study to evaluate metformin as an enhancer treatment and also to find out if it is effective and safe in daylight therapy for ski… Pending

2025-520798-38-00 Actinic keratoses 4
CLINICAL TRIAL WITH APROTININ IN THE ACUTE RESPIRATORY DISTRESS SYNDROME TREATMENT Pending

2025-520826-39-00 ACUTE RESPIRATORY DISTRESS SYNDROME 5
Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending

2025-521086-28-00 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arth 6
Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr… Pending

2025-521301-40-00 Prevention of new morphometric vertebral fractures and/ 6
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting

2024-512436-29-00 CARDIOVASCULAR DISEASES 11 2026-03-27
Effect of pharmacological treatment with angiotensin receptor/neprilysin inhibitors on transthyretin cardiac amyloidosis and heart failure w… Recruiting

2024-515661-34-00 Transthyretin cardiac amyloidosis 6 2025-02-27
Study of efficacy and safety of LNP023 in participants with active lupus nephritis Class III-IV, +/- V Recruiting

2023-509332-26-00 Lupus Nephritis Class III-IV, +/- V 4 2023-02-16
EARLY treatment with Candesartan vs Placebo in asymptomatic GENEtic carriers of Dilated Cardiomyopathy (EARLY-GENE trial) Recruiting

2023-507029-40-00 Genetic carriers of dilated cardiomyopathy causing vari 5 2022-05-09
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting

2024-512726-28-00 peritoneal metastases of colorectal cancer 6 2022-02-14
Clinical trial to assess the efficacy and safety of a vaccine for grasses and olive tree allergy Ended

2024-514525-34-00 Aetiological treatment of moderate-severe intermitent o 5 2024-08-18
Phase II study of Atezolizumab plus Tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal… Ended

2023-509485-38-00 Squamous cell carcinoma of the anal canal 4 2023-03-29
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Spontaneous Coronary Artery Dissection. 6 2021-09-28
Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery Ended

2023-507009-32-00 General anaesthesia 5 2024-05-08
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 Ended

2024-519691-10-00 Septic Shock 6 2022-05-27
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ended

2023-507977-16-00 Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN 4 2021-05-10